TRiC's tricks inhibit huntingtin aggregation

eLife

Volumn 2013, Issue 2, 2013, Pages

  Shahmoradian, Sarah H ^a,c   Galaz Montoya, Jesus G ^a   Schmid, Michael F ^a   Cong, Yao ^a,d   Ma, Boxue ^a   Spiess, Christoph ^b,e   Frydman, Judith ^b   Ludtke, Steven J ^a   Chiu, Wah ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHAPERONIN; CHAPERONIN CONTAINING TCP1; HUNTINGTIN; MUTANT HUNTINGTIN; MUTANT PROTEIN; OLIGOMER; POLYGLUTAMINE; UNCLASSIFIED DRUG; HTT PROTEIN, HUMAN; NERVE PROTEIN; PROTEIN BINDING;

ARTICLE; CAG REPEAT; CRYOELECTRON MICROSCOPY; ELECTRON TOMOGRAPHY; EXON; HUNTINGTON CHOREA; MHTT EXON1; PROTEIN AGGREGATION; GENETICS; HUMAN; METABOLISM; MUTATION;

CRYOELECTRON MICROSCOPY; HUMANS; MUTATION; NERVE TISSUE PROTEINS; PROTEIN BINDING;

EID: 84880084455     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00710     Document Type: Article

References (42)

1. Arrasate M, Finkbeiner S. 2011. Protein aggregates in Huntington's disease. Exp Neurol 238:1-11. doi: 10.1016/j.expneurol.2011.12.013.
2. Bartesaghi A, Sprechmann P, Liu J, Randall G, Sapiro G, Subramaniam S. 2008. Classification and 3D averaging with missing wedge correction in biological electron tomography. J Struct Biol 162:436-50. doi: 10.1016/j.jsb.2008.02.008.
3. Behrends C, Langer CA, Boteva R, Böttcher UM, Stemp MJ, Schaffar G. 2006. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol Cell 23:887-97. doi: 10.1016/j.molcel.2006.08.017.
4. Böhm J, Frangakis AS, Hegerl R, Nickell S, Typke D, Baumeister W. 2000. Toward detecting and identifying macromolecules in a cellular context: template matching applied to electron tomograms. Proc Natl Acad Sci USA 97:14245. doi: 10.1073/pnas.230282097.
5. Booth CR, Meyer AS, Cong Y, Topf M, Sali A, Ludtke SJ, et al. 2008. Mechanism of lid closure in the eukaryotic chaperonin TRiC/CCT. Nat Struct Mol Biol 15:746-53. doi: 10.1038/nsmb.1436.
6. Cong Y, Schröder GF, Meyer AS, Jakana J, Ma B, Dougherty MT, et al. 2012. Symmetry-free cryo-EM structures of the chaperonin TRiC along its ATPase-driven conformational cycle. EMBO J 31:720-30. doi: 10.1038/emboj.2011.366.
7. Dekker C, Roe SM, McCormack EA, Beuron F, Pearl LH, Willison KR. 2011. The crystal structure of yeast CCT reveals intrinsic asymmetry of eukaryotic cytosolic chaperonins. EMBO J 30:3078-90. doi: 10.1038/emboj.2011.208.
8. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. 1997. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-3. doi: 10.1126/science.277.5334.1990.
9. Dubochet J, Adrian M, Chang JJ, Homo JC, Lepault J, McDowall AW, et al. 1988. Cryo-electron microscopy of vitrified specimens. Q Rev Biophys 21:129-228. doi: 10.1017/S0033583500004297.
10. Feldman DE, Spiess C, Howard DE, Frydman J. 2003. Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin binding. Mol Cell 12:1213-24. doi: 10.1016/S1097-2765(03)00423-4.
11. Förster F, Pruggnaller S, Seybert A, Frangakis AS. 2008. Classification of cryo-electron sub-tomograms using constrained correlation. J Struct Biol 161:276-86. doi: 10.1016/j.jsb.2007.07.006.
12. Greiner ER, Yang XW. 2011. Huntington's disease: flipping a switch on huntingtin. Nat Chem Biol 7:412-4. doi: 10.1038/nchembio.604.
13. Hendrick JP, Hartl FU. 1995. The role of molecular chaperones in protein folding. FASEB J 9:1559-69.
14. Kim S, Nollen EA, Kitagawa K, Bindokas VP, Morimoto RI. 2002. Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4:826-31. doi: 10.1038/ncb863.
15. Kitamura A, Kubota H, Pack CG, Matsumoto G, Hirayama S, Takahashi Y, et al. 2006. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol 8:1163-70. doi: 10.1038/ncb1478.
16. Kremer JR, Mastronarde DN, McIntosh JR. 1996. Computer visualization of three-dimensional image data using IMOD. J Struct Biol 116:71-6. doi: 10.1006/jsbi.1996.0013.
17. Liebman SW, Meredith SC. 2010. Protein folding: sticky N17 speeds huntingtin pile-up. Nat Chem Biol 6:7-8. doi: 10.1038/nchembio.279.
18. Llorca O, McCormack EA, Hynes G, Grantham J, Cordell J, Carrascosa JL, et al. 1999. Eukaryotic type II chaperonin CCT interacts with actin through specific subunits. Nature 402:693-6. doi: 10.1038/45294.
19. Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli, et al. 2005. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 102:17342-7. doi: 10.1073/pnas.0506723102.
20. Lunkes A, Lindenberg KS, Ben-Haïem L, Weber C, Devys D, Landwehrmeyer GB, et al. 2002. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol cell 10:259-69. doi: 10.1016/S1097-2765(02)00602-0.
21. Mastronarde DN. 2005. Automated electron microscope tomography using robust prediction of specimen movements. J Struct Biol 152:36-51. doi: 10.1016/j.jsb.2005.07.007.
22. Muchowski PJ, Wacker JL. 2005. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11-22. doi: 10.1038/nrn1587.
23. Muñoz IG, Yébenes H, Zhou M, Mesa P, Serna M, Park AY, et al. 2011. Crystal structure of the open conformation of the mammalian chaperonin CCT in complex with tubulin. Nat Struct Mol Biol 18:14-9. doi: 10.1038/nsmb.1971.
24. Myers RH. 2004. Huntington's disease genetics. NeuroRx 1:255-62. doi: 10.1038/nsmb.1971.
25. Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M. 2009. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci USA 106:9679-84. doi: 10.1073/pnas.0812083106.
26. Nucifora LG, Burke KA, Feng X, Arbez N, Zhu S, Miller J, et al. 2012. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J Biol Chem 287:16017-28. doi: 10.1074/jbc.M111.252577.
27. Rosenthal PB, Henderson R. 2003. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J Mol Biol 333:721-45. doi: 10.1016/j.jmb.2003.07.013.
28. Sarkar S, Ravikumar B, Rubinsztein DC. 2009. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration. Meth Enzymol 45:83-110. doi: 10.1016/S0076-6879(08)04005-6.
29. Sathasivam K, Lane A, Legleiter J, Warley A, Woodman B, Finkbeiner S, et al. 2010. Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum Mol Genet 19:65-78. doi: 10.1093/hmg/ddp467.
30. Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, et al. 1999. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci USA 96:4604-9. doi: 10.1073/pnas.96.8.4604.
31. Schmid MF, Booth CR. 2008. Methods for aligning and for averaging 3D volumes with missing data. J Struct Biol 161:243-48. doi: 10.1016/j.jsb.2007.09.018.
32. Sontag EM, Joachimiak LA, Tan Z, Tomlinson A, Housman DE, Glabe CG, et al. 2013. Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes. Proc Natl Acad Sci USA 110:3077-82. doi: 10.1073/pnas.1222663110.
33. Spiess C, Miller EJ, McClellan AJ, Frydman J. 2006. Identification of the TRiC/CCT substrate binding sites uncovers the function of subunit diversity in eukaryotic chaperonins. Mol Cell 24:25-37. doi: 10.1016/j.molcel.2006.09.003.
34. Tam S, Geller R, Spiess C, Frydman J. 2006. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol 8:1155-62. doi: 10.1038/ncb1477.
35. Tam S, Spiess C, Auyeung W, Joachimiak L, Chen B, Poirier MA, et al. 2009. The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat Struct Mol Biol 16:1279-85. doi: 10.1038/nsmb.1700.
36. Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, et al. 2007. EMAN2: an extensible image processing suite for electron microscopy. J Struct Bio 157:38-46. doi: 10.1016/j.jsb.2006.05.009.
37. Trexler AJ, Rhoades E. 2010. Single molecule characterization of α-synuclein in aggregation-prone states. Biophys J 99:3048-55. doi: 10.1016/j.bpj.2010.08.056.
38. Voisine C, Pedersen JS, Morimoto RI. 2010. Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis 40:12-20. doi: 10.1016/j.nbd.2010.05.007.
39. Walz J, Typke D, Nitsch M, Koster AJ, Hegerl R, Baumeister W. 1997. Electron tomography of single ice-embedded macromolecules: three-dimensional alignment and classification. J Struct Biol 120:387-95. doi: 10.1006/jsbi.1997.3934.
40. Yam AY, Xia Y, Lin H-TJ, Burlingame A, Gerstein M, Frydman J. 2008. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nat Struct Mol Biol 15:1255-62. doi: 10.1038/nsmb.1515.
41. Young JC, Agashe VR, Siegers K, Hartl FU. 2004. Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5:781-91. doi: 10.1038/nrm1492.
42. Zoghbi HY, Orr HT. 2009. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem 284:7425. doi: 10.1074/jbc.R800041200.